News & AnalysisARCH Venture Partners wraps up 12th fund at nearly $3bnARCH Venture Fund XII will back early-stage biotech companies.ByIris Dorbian30 June 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingNorth AmericaUSFundraisingHealthcareBriefs